In addition, BTN3A1 is dysregulated in different types of human cancer, including breast cancer, ovarian cancer, bladder cancer, renal cell carcinoma, and pancreatic ductal adenocarcinoma [14–17]. Here, BTN3A1 is linked to ovarian cancer.